Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue
Clinical trial NCT01611259 · COMPLETED
Trial details
- NCT number
- NCT01611259
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.